MedPath

The Effects of L-arabinose in a Meal in Healthy Men

Not Applicable
Completed
Conditions
Glucose Metabolism
Registration Number
NCT01801540
Lead Sponsor
University of Copenhagen
Brief Summary

The purpose of this study is to investigate the effect of a meal containing different doses of L-arabinose, on the intestinal sucrase activity after intake We measure this by measuring the glucose, insulin and c-peptide after meals. Other measurements are made (glucagon and GLP-1) to explain the correlations.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
17
Inclusion Criteria
  • Healthy male
  • normal weight (BMI 18,5-25 kg/m2)
  • 18-30 years of age
Exclusion Criteria
  • Not healthy,including those with diabetes Mellitus, high bloodpressure, dyslipidemia or a infectious diseases (hepatitis or HIV), gastrointestinal disorders
  • Central adipositas (defined as waist circumference > 94 cm for european men)
  • Daily intake of vitamins and minerals, 3 months before the trail starts and during the trail.
  • elevated alcoholcunsumption(> 21 units af alcohol pr. week)
  • take medicine
  • Elite athlete with intensive training
  • given bloddonation within the last 3 months
  • smoking

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Glucose-15, 0, 15, 30, 45, 60, 90, 120, 180 min

Level of glucose over time, The AUC, the peak value and time to peak

Insulin-15, 0, 15, 30, 45, 60, 90, 120, 180 min

Level of insulin over time, the AUC, the peak value and time to peak

C-peptide-15, 0, 15, 30, 45, 60, 90, 120, 180 min

Level of c-peptide over time, The AUC, the peak value and time to peak

Secondary Outcome Measures
NameTimeMethod
Glucagon-15, 0, 15, 30, 45, 60, 90, 120, 180 min

Level of glucagon over time, The AUC, the peak value and time to peak

GLP-1-15, 0, 15, 30, 45, 60, 90, 120, 180 min

Level of GLP-1 over time, The AUC, the peak value and time to peak

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.